{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:02:00Z","timestamp":1792162920845,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020884","name":"ANID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Global Health"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.langlo.2026.104008","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:54:19Z","timestamp":1783022059000},"page":"104008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Global feasibility of cervical cancer elimination: a multidimensional scenario-based modelling analysis across 175 countries"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2812-0015","authenticated-orcid":false,"given":"Mauricio A","family":"Cuello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6889-976X","authenticated-orcid":false,"given":"Fern\u00e1n","family":"Gomez-Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Wichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander B","family":"Olawaiye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.langlo.2026.104008_bib1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","article-title":"Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Brisson","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.langlo.2026.104008_bib2","series-title":"Global strategy to accelerate the elimination of cervical cancer as a public health problem","year":"2021"},{"key":"10.1016\/j.langlo.2026.104008_bib3","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.langlo.2026.104008_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055470","article-title":"Global trends and age-specific incidence and mortality of cervical cancer from 1990 to 2019: an international comparative study based on the Global Burden of Disease","volume":"12","author":"Yang","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.langlo.2026.104008_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41568-021-00396-4","article-title":"Removing global barriers to cervical cancer prevention and moving towards elimination","volume":"21","author":"Alfaro","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.langlo.2026.104008_bib6","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/s12905-022-02043-y","article-title":"Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: a systematic review","volume":"22","author":"Petersen","year":"2022","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.langlo.2026.104008_bib7","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3390\/v16091357","article-title":"Looking back, moving forward: challenges and opportunities for global cervical cancer prevention and control","volume":"16","author":"Castle","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.langlo.2026.104008_bib8","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S2468-2667(18)30183-X","article-title":"The projected timeframe until cervical cancer elimination in Australia: a modelling study","volume":"4","author":"Hall","year":"2019","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.langlo.2026.104008_bib9","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1470-2045(18)30836-2","article-title":"Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020\u201399: a modelling study","volume":"20","author":"Simms","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.langlo.2026.104008_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185332","article-title":"Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017\u20132035: example from Australia","volume":"13","author":"Hall","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.langlo.2026.104008_bib11","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1038\/s41467-024-47909-x","article-title":"Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer","volume":"15","author":"Arroyo M\u00fchr","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.langlo.2026.104008_bib12","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1016\/S2468-2667(20)30006-2","article-title":"Projected time to elimination of cervical cancer in the USA: a comparative modelling study","volume":"5","author":"Burger","year":"2020","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.langlo.2026.104008_bib13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.langlo.2026.104008_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1386167","article-title":"Cervical cancer prevention by vaccination: review","volume":"14","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.langlo.2026.104008_bib15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(20)30157-4","article-title":"Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Canfell","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.langlo.2026.104008_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12916-025-03897-3","article-title":"Global cervical cancer elimination: quantifying the status, progress, and gaps","volume":"23","author":"Zhou","year":"2025","journal-title":"BMC Med"},{"key":"10.1016\/j.langlo.2026.104008_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0004419","article-title":"Assessing the global implications of the COVID-19 pandemic on the cervical cancer elimination initiative","volume":"5","author":"Loeb","year":"2025","journal-title":"PLOS Glob Public Health"},{"key":"10.1016\/j.langlo.2026.104008_bib18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2471\/BLT.15.164384","article-title":"An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence","volume":"94","author":"Antoni","year":"2016","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.langlo.2026.104008_bib19","series-title":"Cervical cancer country profiles 2021","year":"2021"},{"key":"10.1016\/j.langlo.2026.104008_bib20","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/ijc.29670","article-title":"Cancer Incidence in Five Continents: inclusion criteria, highlights from Volume X and the global status of cancer registration","volume":"137","author":"Bray","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.langlo.2026.104008_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101754","article-title":"Estimating the effect of HIV on cervical cancer elimination in South Africa: comparative modelling of the impact of vaccination and screening","volume":"54","author":"Boily","year":"2022","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.langlo.2026.104008_bib22","doi-asserted-by":"crossref","first-page":"e1115","DOI":"10.1016\/S2214-109X(22)00241-8","article-title":"Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis","volume":"10","author":"Bruni","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.langlo.2026.104008_bib23","doi-asserted-by":"crossref","first-page":"e462","DOI":"10.1016\/S2468-2667(19)30162-8","article-title":"Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study","volume":"4","author":"Xia","year":"2019","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.langlo.2026.104008_bib24","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/dewb.12372","article-title":"Reasons for and insights about HPV vaccination refusal among ultra-Orthodox Jewish mothers","volume":"23","author":"Zach","year":"2023","journal-title":"Dev World Bioeth"},{"key":"10.1016\/j.langlo.2026.104008_bib25","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/S2468-2667(20)30010-4","article-title":"Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study","volume":"5","author":"Simms","year":"2020","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.langlo.2026.104008_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ijgo.12773","article-title":"The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador","volume":"145","author":"Campos","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.langlo.2026.104008_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ijc.33533","article-title":"Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control","volume":"149","author":"Hall","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.langlo.2026.104008_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231388","article-title":"The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: a modelling study","volume":"15","author":"Hall","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.langlo.2026.104008_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nrclinonc.2015.146","article-title":"HPV-FASTER: broadening the scope for prevention of HPV-related cancer","volume":"13","author":"Bosch","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"suppl 1","key":"10.1016\/j.langlo.2026.104008_bib30","doi-asserted-by":"crossref","first-page":"A116","DOI":"10.1016\/j.vaccine.2021.11.013","article-title":"Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review","volume":"40","author":"Wirtz","year":"2022","journal-title":"Vaccine"}],"updated-by":[{"DOI":"10.1016\/j.langlo.2026.104112","type":"expression_of_concern","label":"Expression of concern","source":"publisher","updated":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000}}],"container-title":["The Lancet Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214109X26001701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214109X26001701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:36:06Z","timestamp":1788669366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214109X26001701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2214109X26001701"],"URL":"https:\/\/doi.org\/10.1016\/j.langlo.2026.104008","relation":{},"ISSN":["2214-109X"],"issn-type":[{"value":"2214-109X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global feasibility of cervical cancer elimination: a multidimensional scenario-based modelling analysis across 175 countries","name":"articletitle","label":"Article Title"},{"value":"The Lancet Global Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.langlo.2026.104008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104008"}}